Episode 6 - Disclosure schedules

Shai Swain and Parman Dhillon look into disclosure schedules and disclosure letters, emphasizing their importance in M&A and life science transactions, outlining their general format and purpose, and highlighting the differences between the United States and United Kingdom. The discussion covers key aspects such as intellectual property, material contracts, regulatory compliance, and specific disclosures in life science transactions, concluding with insights on risk apportionment mechanisms and the significance of disclosure exercises in due diligence.